Follow

Submissions from 2025

PDF

Evaluation of Cangrelor Prescribing Trends Across an Acute Care Health-System, Kayla Mitzel, Jonathan Martinez Gines, Jose Valdes Ledesma, Maria A. Ruiz, and Radhan B. Gopalani

PDF

MR-Guided Single-Fraction Stereotactic Ablative Body Radiation Therapy for Extracranial Metastases: The Miami Cancer Institute Experience, Michael Chuong, Robert Herrera, Kathryn Mittauer, Carolina Rojas, Muni Rubens, Adeel Kaiser, Noah Kalman, Nema Bassiri, Antonio Ucar, Federico Albrecht, Fernando deZarraga Jr, Paul Kaywin, Santiago Aparo, Sarah Joseph, Alonso Gutierrez, and Rupesh Kotecha

PDF

Music Therapy in Outpatient Oncology, Alexa Marsellos and Evelyn Erwin

PDF

Random Fourier Features and Ensemble Learning for 30-Day Readmission Risk in Lung Cancer Surgery, Anshul Saxena, Yanjia Zhang, Zhenwei Zhang, Venkataraghavan Ramamoorthy, and Muni Rubens

PDF

NRG Oncology International Consensus Contouring Atlas on Target Volumes and Dosing Strategies for Dose-Escalated Pancreatic Cancer Radiation Therapy, Michael Chuong

PDF

Multidisciplinary management strategies for recurrent brain metastasis after prior radiotherapy: An overview, Rupesh Kotecha and Alonso La Rosa

PDF

Clinical and Genetic Markers of Vascular Toxicity in Glioblastoma Patients: Insights from NRG Oncology RTOG-0825, Minesh Mehta

PDF

Complexity and Experience Grading to Guide Patient Selection for Minimally-invasive Pancreatoduodenectomy: An ISGPS Consensus, Horacio Asbun

PDF

Immune checkpoint inhibitors for glioblastoma: emerging science, clinical advances, and future directions, Manmeet Ahluwalia

PDF

Leptomeningeal metastatic disease: new frontiers and future directions, Manmeet Ahluwalia

A pilot survey into the landscape of neuro-oncology care in the community, Rupesh Kotecha and Yazmin Odia

PDF

Blue Ribbon Committee I Review: Findings and Impact, Michael Zinner

Decorin: matrix-based pan-cancer tumor suppressor, Anshul Saxena, Venkataraghavan Ramamoorthy, Yanjia Zhang, Atulya Khosla, and Muni Rubens

Gabapentinoids confer survival benefit in human glioblastoma, Matthew Hall and Yazmin Odia

Management of Panurethral Strictures by Preputial Graft Urethroplasty: Outcomes From a Tertiary Care Centre, Deerush Sakthivel

Patient-reported outcomes from DESTINY-Breast04: trastuzumab deruxtecan versus physician's choice of chemotherapy in patients with HER2-low mBC, Reshma Mahtani

Perioperative Risks Associated with the Use of External Fixators in Adult and Pediatric Patients with Trauma, Juan Pretell

The Impact of Margin Expansions on Local Control and Radionecrosis Following Stereotactic Radiosurgery for Brain Metastases: A Systematic Review and Meta-Analysis, Rupesh Kotecha

Trends and outcomes of heart failure hospitalizations during COVID-19 pandemic, Muni Rubens; Venkataraghavan Ramamoorthy; Anshul Saxena; Atulya Khosla; Peter McGranaghan; Yanjia Zhang; Sandra , Chaparro; and Javier , Jimenez

Unraveling the Crimson puzzle: Two case reports/case series of hemorrhagic cystitis after combination chemotherapy with docetaxel, carboplatin, trastuzumab and pertuzumab in breast cancer, Grace Wang, Yolcar Chamorro, and Ana Sandoval-Leon

Submissions from 2024

PDF

Financial barriers and inequity in medical education in India: challenges to training a diverse and representative healthcare workforce, Manmeet Ahluwalia

PDF

Comparison of Stereotactic Radiosurgery and Hypofractionated Radiosurgery for Vestibular Schwannomas: A Meta-Analysis of Available Literature, Manmeet Ahluwalia

HER2+ early breast cancer treatment and outcomes by risk of recurrence: a retrospective US electronic health records study, Reshma Mahtani

Multicenter retrospective cohort study of the sequential use of antibody drug conjugates (ADCs) trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in patients with HER2 low metastatic breast cancer (MBC): a subgroup analysis of next generation sequencing results., Reshma Mahtani, Mehmet Zerey, Ana Cristina Sandoval Leon, Lauren Carcas, Joseph Panoff, and Manmeet Ahluwalia

Multi-Institutional Quality Improvement on HER2-Positive and HER2-Low Metastatic Breast Cancer, Reshma Mahtani